$HYPR Cashflow Statement | Understand Stock

$HYPR

$0.76 +$0.03 (4.54%) Live

$HYPR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Write-down of inventory
Write-off of other assets - related party
Write-off of equipment
Change in fair value of warrant liabilities
Other
Payments received on net investment in lease

Changes in assets and liabilities:
Accounts receivable
Unbilled receivables
Inventory
Prepaid expenses and other current assets
Due from related parties
Other assets - related party
Prepaid inventory
Other long term assets
Accounts payable
Deferred grant funding
Deferred revenue
Due to related parties
Accrued expenses and other current liabilities
Operating lease liabilities, net

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from exercise of stock options
Proceeds from issuance of Series D convertible preferred stock
Stock issuance costs related to Series D convertible preferred stock
Repayment of notes payable
Investment from 4Bionics, LLC
Proceeds from shares issued under ATM Sales Agreement, net of selling costs
Proceeds from issuance of Class A common stock in connection with warrant exercises
Net cash provided by financing activities

Net decrease in cash and cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of year
Cash, cash equivalents and restricted cash, end of year
Cash received from exchange of research and development tax credits
Supplemental disclosure of noncash information:
Write-off of notes receivable
Issuance of Class A Common Stock to a service provider in exchange for the service provided in connection with the Business Combination
Noncash acquisition of property and equipment
Unpaid purchase of property and equipment
Initial measurement of warrant liabilities

Reconciliation of cash, cash equivalents, and restricted cash reported in the balance sheets
Cash and cash equivalents
Restricted cash

Comments